Global Thymosin a1 Market Outlook

Publish Date: Aug 2019

Report Code: VMR1308A

Publisher: Verified Market Research

Single User License: $3950

Explore Our Services

Already a member? Login here.

Report Highlights

What is Thymosin α1?

Thymosin α1 is a protein in humans encoded by the PTMA gene, which is a peptide fragment derived from prothymosin alpha, exhibits a variety of immunoregulating properties. It is approved for the treatment of Hepatitis B and C, in 35 under-developed or developing countries.

Global Thymosin α1 Market Outlook

The rising burden and incidence of HAV and HBV are driving the growth of Thymosin α1 market. In 2015, 257 million people were diagnosed with chronic HBV infection, and 71 million people with chronic HCV infection, this figure to reach a peak by 2030. Eastern Mediterranean Region and the European Region are reported with the highest prevalence of HCV. 
Ongoing trials and research for new applications or treatments to propel the growth of the market. Clinical trials entail that thymosin α1 can be useful in cystic fibrosis, peritonitis, acute cytomegalovirus infection, TB, severe acute respiratory syndrome, and lung infections in critically ill patients., septic shock and acute respiratory distress syndrome. It has been studied for probable use in treating cancer during chemotherapy. Thymosin α1 has been given to subjects with lung, gastric, or breast cancer in China. It was given for evaluation during one of two cycles of chemotherapy and QOL, treatment with Thymosin α1 provided a significant improvement in all measures of QOL as well as a lowered occurrence of infections during chemotherapy and increased immune parameters. Lack of awareness among the rural population about hepatitis and its treatment is hindering the growth of the market.

Global Thymosin α1 Market Competitive Landscape

The “Global Thymosin α1 Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical, Hainan Zhonghe Pharmaceutical, SciClone Pharmaceuticals, Abbiotec, Shanghai Soho-Yiming Pharmaceuticals, Hybio Pharmaceutical and Hainan Shuangcheng Pharmaceuticals. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report

• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Thymosin a1 Market Outlook